Beijing Aosaikang Pharmaceutical Future Growth
Future criteria checks 2/6
Beijing Aosaikang Pharmaceutical is forecast to grow earnings and revenue by 21.7% and 13.6% per annum respectively. EPS is expected to grow by 22.9% per annum. Return on equity is forecast to be 4.7% in 3 years.
Key information
21.7%
Earnings growth rate
22.9%
EPS growth rate
| Pharmaceuticals earnings growth | 18.9% |
| Revenue growth rate | 13.6% |
| Future return on equity | 4.7% |
| Analyst coverage | Low |
| Last updated | 23 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking
Oct 18
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?
Oct 11Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem
Sep 05Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues
May 21Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump
Mar 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,315 | 174 | 70 | 90 | 1 |
| 12/31/2025 | 1,999 | 74 | -36 | 2 | 1 |
| 12/31/2024 | 1,773 | 32 | -173 | -69 | 1 |
| 9/30/2024 | 1,708 | 163 | 277 | 430 | N/A |
| 6/30/2024 | 1,654 | 86 | 205 | 366 | N/A |
| 3/31/2024 | 1,553 | -48 | 122 | 283 | N/A |
| 12/31/2023 | 1,443 | -149 | -156 | -27 | N/A |
| 9/30/2023 | 1,486 | -342 | -251 | -102 | N/A |
| 6/30/2023 | 1,574 | -397 | -258 | -114 | N/A |
| 3/31/2023 | 1,676 | -314 | -331 | -183 | N/A |
| 1/1/2023 | 1,873 | -226 | -203 | -53 | N/A |
| 9/30/2022 | 2,169 | -80 | 201 | 327 | N/A |
| 6/30/2022 | 2,443 | 129 | 179 | 281 | N/A |
| 3/31/2022 | 2,711 | 221 | 430 | 534 | N/A |
| 1/1/2022 | 3,107 | 380 | 434 | 568 | N/A |
| 9/30/2021 | 3,513 | 634 | 328 | 437 | N/A |
| 6/30/2021 | 3,954 | 757 | 458 | 599 | N/A |
| 3/31/2021 | 4,005 | 793 | 352 | 462 | N/A |
| 12/31/2020 | 3,783 | 722 | 381 | 580 | N/A |
| 9/30/2020 | 3,697 | 674 | 266 | 504 | N/A |
| 6/30/2020 | 3,720 | 627 | 222 | 490 | N/A |
| 3/31/2020 | 4,114 | 699 | 376 | 669 | N/A |
| 12/31/2019 | 4,519 | 781 | 366 | 535 | N/A |
| 9/30/2019 | 4,507 | 773 | 346 | 493 | N/A |
| 6/30/2019 | 4,279 | 729 | 411 | 506 | N/A |
| 3/31/2019 | 4,068 | 699 | 285 | 363 | N/A |
| 12/31/2018 | 3,932 | 670 | 401 | 497 | N/A |
| 12/31/2017 | 3,405 | 608 | N/A | 686 | N/A |
| 12/31/2016 | 3,092 | 630 | N/A | 786 | N/A |
| 12/31/2015 | 3,011 | 509 | N/A | 689 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002755's forecast earnings growth (21.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 002755's earnings (21.7% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 002755's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 002755's revenue (13.6% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 002755's revenue (13.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002755's Return on Equity is forecast to be low in 3 years time (4.7%).